Close Menu
    Beijing ScoopBeijing Scoop
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • Sports
    • Technology
    • Travel
    Beijing ScoopBeijing Scoop
    Home » Abu Dhabi Department of Health collaborates with Johnson & Johnson
    Health

    Abu Dhabi Department of Health collaborates with Johnson & Johnson

    June 16, 2022
    Facebook WhatsApp Twitter Pinterest LinkedIn Telegram Tumblr Email Reddit VKontakte

    Department of Health Abu Dhabi (DoH), the regulator of healthcare in the emirate, has signed a Declaration of Collaboration with Johnson & Johnson Middle East FZ-LLC to support Abu Dhabi’s vision of developing a regional center for clinical research and data generation. In addition to bringing innovative treatments and breakthrough solutions to the UAE and the MENA region, the collaboration will also allow for the exchange of knowledge and experiences across the health sector.

    Abu Dhabi Department of Health collaborates with Johnson & JohnsonThe signing ceremony, witnessed by Abdullah bin Mohammed Al Hamed, Chairman of the Department of Health Abu Dhabi (DoH), took place during BIO International Convention 2022, held between 13-16 June in San Diego, California. The Declaration of Collaboration was signed by Dr. Asma Al Mannaei, Executive Director, Research and Innovation Centre at DoH, and Jamie Phares, Managing Director of Janssen GCC, one of Johnson and Johnson’s pharmaceutical companies.

    The Abu Dhabi delegation will showcase the growth and development of Abu Dhabi’s biotechnology industry at BIO International Convention 2022. The collaborations will explore key potential areas of interest for developing short and long-term projects in the generation of Data and Real-World Evidence (RWE). In order to establish the strength and sustainability of the healthcare sector and to provide patient care of a high standard, Abu Dhabi seeks to lead research groups supported by global partners.

    With a robust growth potential, Abu Dhabi’s biopharmaceutical and healthcare value chain continues to see collaboration opportunities emerge due to its strong infrastructure and advanced healthcare ecosystem. Through international collaborations, Abu Dhabi seeks to lead research groups supported by global partners to explore the resilience and sustainability of the healthcare sector worldwide as well as provide quality care to patients.

    Related Posts

    Ebola adds 60 cases in a day as Congo deaths hit 5,568

    November 18, 2026

    Ebola cases top 11,200 as Africa CDC warns of record outbreak

    November 16, 2026

    Yellow fever kills 18 across nine African nations, WHO says

    November 7, 2026

    Dengue kills 173 in October as Bangladesh toll climbs to 418

    November 2, 2026

    Ebola deaths in DR Congo reach 5,340, fatality rate at 51.6%

    November 2, 2026

    Ebola death toll in DR Congo nears 4,900 as cases pass 10,000

    October 28, 2026
    Latest News

    Air Arabia Egypt launches Cairo to Al Ain flights soon

    November 20, 2026

    Botswana opens consultations on proposed 33 percent hike now

    November 19, 2026

    PM Modi meets Prince and Princess of Wales for climate talks

    November 19, 2026

    Rand slips toward R17 as inflation and weak growth cloud outlook

    November 18, 2026

    Ebola adds 60 cases in a day as Congo deaths hit 5,568

    November 18, 2026

    Dubai Airports expects over 70 million guests in 2026

    November 18, 2026

    Prabowo says DEFA can unlock $2 trillion ASEAN digital economy

    November 18, 2026

    Over 9 million visitors lift Tunisia tourism income 3.4%

    November 17, 2026
    © 2026 Beijing Scoop | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.